Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlyle (CG) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Carlyle (CG) over the last 15 years, with Q3 2025 value amounting to $2.2 billion.

  • Carlyle's Cash & Equivalents rose 6136.69% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year increase of 6136.69%. This contributed to the annual value of $1.3 billion for FY2024, which is 1210.16% down from last year.
  • As of Q3 2025, Carlyle's Cash & Equivalents stood at $2.2 billion, which was up 6136.69% from $1.3 billion recorded in Q2 2025.
  • Carlyle's Cash & Equivalents' 5-year high stood at $2.5 billion during Q4 2021, with a 5-year trough of $870.3 million in Q2 2023.
  • For the 5-year period, Carlyle's Cash & Equivalents averaged around $1.4 billion, with its median value being $1.3 billion (2022).
  • In the last 5 years, Carlyle's Cash & Equivalents soared by 18605.95% in 2021 and then plummeted by 4489.98% in 2022.
  • Quarter analysis of 5 years shows Carlyle's Cash & Equivalents stood at $2.5 billion in 2021, then tumbled by 44.9% to $1.4 billion in 2022, then rose by 5.85% to $1.4 billion in 2023, then fell by 12.1% to $1.3 billion in 2024, then surged by 75.49% to $2.2 billion in 2025.
  • Its Cash & Equivalents was $2.2 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.2 billion in Q1 2025.